These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25821319)

  • 21. Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis.
    Vardakas KZ; Mavroudis AD; Georgiou M; Falagas ME
    Int J Antimicrob Agents; 2018 Apr; 51(4):535-547. PubMed ID: 29288723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bloodstream infections caused by Acinetobacter species with reduced susceptibility to tigecycline: clinical features and risk factors.
    Park GE; Kang CI; Cha MK; Cho SY; Seok H; Lee JH; Kim JY; Ha YE; Chung DR; Peck KR; Lee NY; Song JH
    Int J Infect Dis; 2017 Sep; 62():26-31. PubMed ID: 28676346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis.
    Leão AC; Menezes PR; Oliveira MS; Levin AS
    BMC Infect Dis; 2016 Aug; 16():386. PubMed ID: 27506948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection.
    Chen Z; Chen Y; Fang Y; Wang X; Chen Y; Qi Q; Huang F; Xiao X
    Sci Rep; 2015 Nov; 5():17091. PubMed ID: 26597507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients.
    Kim WY; Moon JY; Huh JW; Choi SH; Lim CM; Koh Y; Chong YP; Hong SB
    PLoS One; 2016; 11(3):e0150642. PubMed ID: 26934182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China.
    Liu Q; Li W; Du X; Li W; Zhong T; Tang Y; Feng Y; Tao C; Xie Y
    PLoS One; 2015; 10(6):e0130701. PubMed ID: 26083415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia.
    Lee CH; Tang YF; Su LH; Chien CC; Liu JW
    Microb Drug Resist; 2008 Sep; 14(3):233-7. PubMed ID: 18707240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance.
    Wareham DW; Bean DC; Khanna P; Hennessy EM; Krahe D; Ely A; Millar M
    Eur J Clin Microbiol Infect Dis; 2008 Jul; 27(7):607-12. PubMed ID: 18283503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.
    Shi J; Sun T; Cui Y; Wang C; Wang F; Zhou Y; Miao H; Shan Y; Zhang Y
    BMC Infect Dis; 2020 Aug; 20(1):597. PubMed ID: 32787942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
    Shah PG; Shah SR
    J Assoc Physicians India; 2015 Jul; 63(7):14-8. PubMed ID: 26731822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety profile comparison of colistin and tigecycline on the extensively drug resistant Acinetobacter baumannii.
    Kwon SH; Ahn HL; Han OY; La HO
    Biol Pharm Bull; 2014; 37(3):340-6. PubMed ID: 24583855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii.
    Katip W; Uitrakul S; Oberdorfer P
    Int J Infect Dis; 2020 Aug; 97():391-395. PubMed ID: 32502665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy.
    Lee YT; Wang YC; Kuo SC; Chen CT; Liu CP; Liu YM; Chen TL; Yang YS
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients.
    Trottier V; Namias N; Pust DG; Nuwayhid Z; Manning R; Marttos AC; Dunham MB; Schulman CI; McKenney MG
    Surg Infect (Larchmt); 2007 Aug; 8(4):437-43. PubMed ID: 17883360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia.
    Metan G; Sariguzel F; Sumerkan B
    Eur J Intern Med; 2009 Sep; 20(5):540-4. PubMed ID: 19712862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors, Clinical Presentation, and Outcome of
    Ballouz T; Aridi J; Afif C; Irani J; Lakis C; Nasreddine R; Azar E
    Front Cell Infect Microbiol; 2017; 7():156. PubMed ID: 28523249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of aerosolized colistin methanesulfonate therapy for extensively-drug-resistant Acinetobacter baumannii complex pneumonia and airway colonization.
    Hsieh TC; Chen FL; Ou TY; Jean SS; Lee WS
    J Microbiol Immunol Infect; 2016 Aug; 49(4):523-30. PubMed ID: 25442877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.
    Chen CT; Wang YC; Kuo SC; Shih FH; Chen TL; How CK; Yang YS; Lee YT
    J Microbiol Immunol Infect; 2018 Oct; 51(5):629-635. PubMed ID: 28701266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?
    Kalin G; Alp E; Coskun R; Demiraslan H; Gündogan K; Doganay M
    J Infect Chemother; 2012 Dec; 18(6):872-7. PubMed ID: 22644081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia.
    Yilmaz GR; Guven T; Guner R; Kocak Tufan Z; Izdes S; Tasyaran MA; Acikgoz ZC
    J Infect Dev Ctries; 2015 May; 9(5):476-85. PubMed ID: 25989167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.